Met Life Investment Management, LLC C4 Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 35,455 shares of CCCC stock, worth $140,047. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,455
Previous 15,477 129.08%
Holding current value
$140,047
Previous $71,000 184.51%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$4.43 - $7.38 $88,502 - $147,437
19,978 Added 129.08%
35,455 $202,000
Q2 2024

Aug 13, 2024
BUY
$4.05 - $8.1 $62,681 - $125,363
15,477 New
15,477 $71,000
Q1 2023

May 09, 2024
BUY
$3.1 - $9.02 $85,172 - $247,824
27,475 New
27,475 $86.3 Million
Q3 2022

May 10, 2024
BUY
$8.03 - $12.77 $51,094 - $81,255
6,363 Added 30.14%
27,475 $240,000
Q3 2022

Mar 22, 2023
BUY
$8.03 - $12.77 $51,094 - $81,255
6,363 Added 30.14%
27,475 $240,000
Q3 2022

Nov 14, 2022
BUY
$8.03 - $12.77 $51,094 - $81,255
6,363 Added 30.14%
27,475 $241,000
Q2 2022

Jun 20, 2023
SELL
$5.06 - $26.46 $32,196 - $168,364
-6,363 Reduced 23.16%
21,112 $159,000
Q1 2022

May 10, 2024
BUY
$19.99 - $33.23 $422,028 - $701,551
21,112 New
21,112 $512,000
Q1 2022

Jun 20, 2023
SELL
$19.99 - $33.23 $127,196 - $211,442
-6,363 Reduced 23.16%
21,112 $512,000
Q1 2022

Mar 22, 2023
BUY
$19.99 - $33.23 $155,762 - $258,928
7,792 Added 58.5%
21,112 $512,000
Q1 2022

May 12, 2022
BUY
$19.99 - $33.23 $155,762 - $258,928
7,792 Added 58.5%
21,112 $512,000
Q4 2021

Jun 21, 2023
SELL
$29.39 - $46.86 $416,015 - $663,303
-14,155 Reduced 51.52%
13,320 $428,000
Q3 2021

Jun 21, 2023
SELL
$35.91 - $50.5 $508,306 - $714,827
-14,155 Reduced 51.52%
13,320 $595,000
Q2 2021

May 17, 2024
BUY
$30.39 - $42.18 $242,269 - $336,258
7,972 Added 149.07%
13,320 $504,000
Q2 2021

Jun 21, 2023
SELL
$30.39 - $42.18 $430,170 - $597,057
-14,155 Reduced 51.52%
13,320 $504,000
Q2 2021

Mar 22, 2023
BUY
$30.39 - $42.18 $242,269 - $336,258
7,972 Added 149.07%
13,320 $504,000
Q2 2021

Aug 16, 2021
BUY
$30.39 - $42.18 $242,269 - $336,258
7,972 Added 149.07%
13,320 $504,000
Q1 2021

May 17, 2024
BUY
$31.96 - $46.5 $170,922 - $248,682
5,348 New
5,348 $197,000
Q1 2021

Jun 26, 2023
SELL
$31.96 - $46.5 $707,178 - $1.03 Million
-22,127 Reduced 80.54%
5,348 $198 Million
Q4 2020

May 24, 2024
BUY
$22.8 - $37.05 $121,934 - $198,143
5,348 New
5,348 $177,000
Q4 2020

Jun 22, 2023
SELL
$22.8 - $37.05 $504,495 - $819,805
-22,127 Reduced 80.54%
5,348 $177,000
Q4 2020

Mar 22, 2023
SELL
$22.8 - $37.05 $504,495 - $819,805
-22,127 Reduced 80.54%
5,348 $177,000
Q4 2020

Feb 16, 2021
BUY
$22.8 - $37.05 $121,934 - $198,143
5,348 New
5,348 $177,000

Others Institutions Holding CCCC

# of Institutions
130
Shares Held
63.5M
Call Options Held
670K
Put Options Held
54.8K
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $193M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email